Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV002439676 | SCV002746265 | uncertain significance | Cardiovascular phenotype | 2022-01-19 | criteria provided, single submitter | clinical testing | The p.T372S variant (also known as c.1114A>T), located in coding exon 6 of the SNTA1 gene, results from an A to T substitution at nucleotide position 1114. The threonine at codon 372 is replaced by serine, an amino acid with similar properties. This amino acid position is conserved. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |